Based on the empirically established role of GH in cancer progression [10,13,14,21,23,76], our findings reveal that elevated tumoral GHR expression in NSCLC is associated with the upregulation of gene signatures involved in key oncogenic processes. This evidence concerns the gene GHR and non-small cell lung carcinoma.